Race Oncology Limited (RAONF)
OTCMKTS · Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Jul 11, 2024

Race Oncology Statistics

Total Valuation

Race Oncology has a market cap or net worth of 148.80 million. The enterprise value is 138.09 million.

Market Cap 148.80M
Enterprise Value 138.09M

Important Dates

The next estimated earnings date is Sunday, February 23, 2025.

Earnings Date Feb 23, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +2.35%
Shares Change (QoQ) +1.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 120.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 14.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -14.98
EV / Sales 55.37
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.32

Current Ratio 9.32
Quick Ratio 9.26
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -63.10% and return on invested capital (ROIC) is -41.34%.

Return on Equity (ROE) -63.10%
Return on Assets (ROA) -38.63%
Return on Capital (ROIC) -41.34%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.86% in the last 52 weeks. The beta is 1.74, so Race Oncology's price volatility has been higher than the market average.

Beta (5Y) 1.74
52-Week Price Change -15.86%
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 3,442

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Race Oncology had revenue of 2.67 million and -9.22 million in losses. Loss per share was -0.06.

Revenue 2.67M
Gross Profit 927,352
Operating Income -9.66M
Pretax Income -9.22M
Net Income -9.22M
EBITDA -9.48M
EBIT -9.66M
Loss Per Share -0.06
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 11.47M
Total Debt n/a
Net Cash 11.47M
Net Cash Per Share n/a
Equity (Book Value) 12.22M
Book Value Per Share 0.07
Working Capital 10.37M
Full Balance Sheet

Cash Flow

Operating Cash Flow -6.37M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 34.72%
Operating Margin -361.80%
Pretax Margin -345.18%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Race Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.35%
Shareholder Yield -2.35%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Race Oncology has an Altman Z-Score of 52.36.

Altman Z-Score 52.36
Piotroski F-Score n/a